These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25769296)

  • 1. Drug treatments for rheumatoid arthritis: looking backwards to move forwards.
    Miossec P
    BMJ; 2015 Mar; 350():h1192. PubMed ID: 25769296
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to disease modifying treatments for rheumatoid arthritis patients.
    Furst DE; Breedveld FC; Burmester GR; Crofford L; Emery P; Feldman M; Kalden JR; Kavanaugh A; Keystone E; Lipsky PE; Maini RN; Moreland L; Smolen JS; Van De Putte L; Vischer T; Weinblatt M; Weissman M
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I129-30. PubMed ID: 10577989
    [No Abstract]   [Full Text] [Related]  

  • 3. The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis.
    Kavanaugh A; Cohen S; Cush JJ
    J Rheumatol; 2004 Oct; 31(10):1881-4. PubMed ID: 15468347
    [No Abstract]   [Full Text] [Related]  

  • 4. New drugs for rheumatoid arthritis.
    Roberts LJ
    N Engl J Med; 2004 Dec; 351(25):2659-61; author reply 2659-61. PubMed ID: 15602032
    [No Abstract]   [Full Text] [Related]  

  • 5. Rheumatoid arthritis.
    Burchini G; Orsi C
    N Engl J Med; 2004 Sep; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
    [No Abstract]   [Full Text] [Related]  

  • 6. Drivers of costly treatment strategies in rheumatoid arthritis.
    Huizinga TW; Gröndal G
    Lancet; 2016 Jul; 388(10041):213-4. PubMed ID: 27197691
    [No Abstract]   [Full Text] [Related]  

  • 7. Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.
    Redlich K; Schett G; Steiner G; Hayer S; Wagner EF; Smolen JS
    Arthritis Rheum; 2003 Dec; 48(12):3308-19. PubMed ID: 14673982
    [No Abstract]   [Full Text] [Related]  

  • 8. Avoiding common pitfalls in the analysis of observational studies of new treatments for rheumatoid arthritis.
    Hudson M; Suissa S
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):805-10. PubMed ID: 20535791
    [No Abstract]   [Full Text] [Related]  

  • 9. Adalimumab for rheumatoid arthritis?
    Ebell M; Kripke C
    Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
    [No Abstract]   [Full Text] [Related]  

  • 10. [TNF-alpha blocker in rheumatoid arthritis. Who should be treated with the new substances?].
    MMW Fortschr Med; 2000 Nov; 142(44):6. PubMed ID: 11107796
    [No Abstract]   [Full Text] [Related]  

  • 11. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
    Weisman MH
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness and safety of the treatment with tumour necrosis factor alpha antagonists in rheumatoid arthritis patients].
    Arenere Mendoza M; Navarro Aznárez H; Rabanaque Hernández MJ; Manero Ruiz FJ
    Med Clin (Barc); 2005 Jun; 125(1):35-6. PubMed ID: 15960943
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rheumatoid arthritis: determination of the current status].
    Michel BA
    Z Rheumatol; 2001 Oct; 60(5):307-8. PubMed ID: 11759229
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA perspective on anti-TNF treatments.
    Schwieterman WD
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I90-1. PubMed ID: 10577981
    [No Abstract]   [Full Text] [Related]  

  • 15. TNF alpha blockade in rheumatoid arthritis--time for caution or enthusiasm?
    Hamilton JD; Wilson HE; Madhok R; McInnes IB; Capell HA
    Scott Med J; 2001 Jun; 46(3):67-70. PubMed ID: 11501322
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis?
    Kavanaugh A
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):346-7. PubMed ID: 16932716
    [No Abstract]   [Full Text] [Related]  

  • 17. [TNF-alpha antagonists in therapy of rheumatoid arthritis].
    Gross WL; Gause A
    Z Rheumatol; 2003 Jun; 62(3):217. PubMed ID: 12931691
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of tumor necrosis factor-alpha inhibitors on lung lesions with rheumatoid arthritis.
    Inoue K; Takano H; Yanagisawa R; Yoshikawa T
    Chest; 2003 Jul; 124(1):413-4; author reply 414. PubMed ID: 12853558
    [No Abstract]   [Full Text] [Related]  

  • 19. When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
    Smolen JS; Weinblatt ME
    Ann Rheum Dis; 2008 Nov; 67(11):1497-8. PubMed ID: 18854512
    [No Abstract]   [Full Text] [Related]  

  • 20. BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
    Bukhari M; Abernethy R; Deighton C; Ding T; Hyrich K; Lunt M; Luqmani R; Kiely P; Bosworth A; Ledingham J; Ostör A; Gadsby K; McKenna F; Finney D; Dixey J;
    Rheumatology (Oxford); 2011 Dec; 50(12):2311-3. PubMed ID: 21546351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.